Loading stock research

Positron Corporation

POSC

HealthcareOTCUS

Sign in to save

$1.86

-$0.028 (-1.48%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

POSC News

News and disclosures filtered by period, publisher, and event group.

2 / 2

Filter options

Results

Select a headline to open the full news page in the app.

Apr 2, 2026, 1:59 AMdefenseworld.netPOSC

Head-To-Head Review: Positron (OTCMKTS:POSC) versus Pressure BioSciences (OTCMKTS:PBIO)

Capital and holders

Institutional and Insider Ownership 0.0% of Pressure BioSciences shares are owned by institutional investors. 10.8% of Pressure BioSciences shares are owned by company insiders. Comparatively, 17.2% of Positron shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term

Mar 11, 2026, 1:02 AMdefenseworld.netOfficialPOSC

Contrasting Positron (OTCMKTS:POSC) and AngioDynamics (NASDAQ:ANGO)

Financial reportsProfit distribution and payments

Positron (OTCMKTS:POSC - Get Free Report) and AngioDynamics (NASDAQ: ANGO - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, analyst recommendations, valuation, earnings and risk. Earnings and Valuation This table compares Positron and AngioDynamics"s

Loading disclosure news